Scientists hunt for hidden biomarkers to solve antidepressant failure
NCT ID NCT03118193
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aimed to find biological markers in blood, urine, and saliva that could help explain why up to 40% of people with depression do not respond to standard antidepressants. Researchers analyzed samples from 50 adults with major depression who had not taken antidepressants for at least two weeks. The goal was to better understand the disease and potentially guide more personalized treatment in the future.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEPRESSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU Tours
Tours, 37044, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A computer program may help tame depression and stress — without a therapist
- Can a Four-Week program ease the burden on autism caregivers?
- Two digital programs put to the test for everyday mental health struggles
- Could a simple conversation change how doctors treat mental illness?
- Digital sleep and mood programs put to the test for breast cancer survivors
- Antidepressants may rewire how the brain perceives control